The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Identification of the C3a Receptor (C3AR1) as the Target of the VGF-derived Peptide TLQP-21 in Rodent Cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TLQP-21 is found in the sympathetic nerve terminals in the adipose tissue and targets the G-protein-coupled-receptor (GPCR) Complement-3a-Receptor1 (C3aR1).”
From The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism (2014) · cites this paper as Hannedouche et al., 2013
In the citing paper
“In CHO and HeK239 cells transfected with C3aR1, TLQP-21 binds the receptor with 100 fold lower affinity than C3a (Hannedouche et al., 2013)”
From The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism (2014) · cites this paper as Hannedouche et al., 2013
In the citing paper
“Published (Possenti et al., 2012, Hannedouche et al., 2013, Passina et al., 2013) and current data do not support a second binding site in either CHO or 3T3L1 cells (Figure 1)”
From The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism (2014) · cites this paper as Hannedouche et al., 2013
In the citing paper
“A recent study reported that the human TLQP-21 sequence is 5-fold less potent toward the rodent C3aR1 than the corresponding rodent sequence (Hannedouche et al., 2013).”
From The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism (2014) · cites this paper as Hannedouche et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
Xu, X., Nagarajan, H., Lewis, N. E., Pan, S., Cai, Z., Liu, X., Chen, W., Xie, M., Wang, W., Hammond, S., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1932 · Cited by 785
The role of the anaphylatoxins in health and disease
Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730 · cited 1×
“Originally, C3AR1 was thought to be restricted to the innate immune response, having a role in the complement cascade, but its participation has been extended to roles in cancer (20), neurogenesis (21), and hormone release from the pituitary gland (22).”
Background
Research works printed but not linked: 38
- Ferri, 2011, VGF: an inducible gene product, precursor of a diverse array of neuro-endocrine peptides and tissue-specific disease biomarkers, J. Chem. Neuroanat, 42, 249, 10.1016/j.jchemneu.2011.05.007 · DOI
- Hahm, 1999, Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance, Neuron, 23, 537, 10.1016/S0896-6273(00)80806-5 · DOI · Paper page
- Bartolomucci, 2006, TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity, Proc. Natl. Acad. Sci. U.S.A, 103, 14584, 10.1073/pnas.0606102103 · DOI · Paper page
- Bartolomucci, 2007, Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice, Growth Horm. IGF Res, 17, 342, 10.1016/j.ghir.2007.02.002 · doi:10.1016/j.ghir.2007.02.002
- Jethwa, 2007, VGF-derived peptide, TLQP-21, regulates food intake and body weight in Siberian hamsters, Endocrinology, 148, 4044, 10.1210/en.2007-0038 · DOI · Paper page
- Bartolomucci, 2009, Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice, Genes Nutr, 4, 49, 10.1007/s12263-009-0110-0 · DOI
- Petrella, 2012, TLQP-21, a VGF-derived peptide, stimulates exocrine pancreatic secretion in the rat, Peptides, 36, 133, 10.1016/j.peptides.2012.03.035 · DOI · Paper page
- Possenti, 2012, Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21, Biochem. J, 441, 511, 10.1042/BJ20111165 · DOI · Paper page
- Sibilia, 2012, Characterization of the mechanisms involved in the gastric antisecretory effect of TLQP-21, a vgf-derived peptide, in rats, Amino. Acids, 42, 1261, 10.1007/s00726-010-0818-6 · DOI
- Severini, 2009, In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions, Br. J. Pharmacol, 157, 984, 10.1111/j.1476-5381.2009.00192.x · DOI · Paper page
- Brancia, 2010, Selective expression of TLQP-21 and other VGF peptides in gastric neuroendocrine cells and modulation by feeding, J. Endocrinol, 207, 329, 10.1677/JOE-10-0189 · doi:10.1677/joe-10-0189
- Stephens, 2012, A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet β-cell survival and function, Cell Metab, 16, 33, 10.1016/j.cmet.2012.05.011 · DOI · Paper page
- Petrocchi Passeri, 2013, Neuropeptide TLQP-21, a VGF internal fragment, modulates hormonal gene expression and secretion in GH3 cell line, Neuroendocrinology, 97, 212, 10.1159/000339855 · doi:10.1159/000339855
- Razzoli, 2012, Implication of the VGF-derived peptide TLQP-21 in mouse acute and chronic stress responses, Behav. Brain Res, 229, 333, 10.1016/j.bbr.2012.01.038 · DOI
- Pinilla, 2011, Characterization of the reproductive effects of the anorexigenic VGF-derived peptide TLQP-21: in vivo and in vitro studies in male rats, Am. J. Physiol. Endocrinol. Metab, 300, E837, 10.1152/ajpendo.00598.2010 · DOI
- Cassina, 2013, Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity, Biochim. Biophys. Acta, 1828, 455, 10.1016/j.bbamem.2012.10.023 · DOI · Paper page
- Mortazavi, 2008, Mapping and quantifying mammalian transcriptomes by RNA-Seq, Nat. Methods, 5, 621, 10.1038/nmeth.1226 · DOI · Paper page
- Wang, 2009, RNA-Seq: a revolutionary tool for transcriptomics, Nat. Rev. Genet, 10, 57, 10.1038/nrg2484 · DOI · Paper page
- Jiménez-Guri, 2013, Comparative transcriptomics of early dipteran development, BMC Genomics, 14, 123, 10.1186/1471-2164-14-123 · DOI
- Opstal-van Winden, 2012, Early diagnostic protein biomarkers for breast cancer: how far have we come?, Breast Cancer Res. Treat, 134, 1, 10.1007/s10549-011-1907-2 · DOI
- Francis, 2003, Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation, FASEB J, 17, 2266, 10.1096/fj.02-1103fje · DOI
- Mamane, 2009, The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation, Diabetes, 58, 2006, 10.2337/db09-0323 · DOI · Paper page
- Trapnell, 2009, TopHat: discovering splice junctions with RNA-Seq, Bioinformatics, 25, 1105, 10.1093/bioinformatics/btp120 · DOI · Paper page
- Langmead, 2009, Ultrafast and memory-efficient alignment of short DNA sequences to the human genome, Genome Biol, 10, R25, 10.1186/gb-2009-10-3-r25 · DOI · Paper page
- Roberts, 2011, Identification of novel transcripts in annotated genomes using RNA-Seq, Bioinformatics, 27, 2325, 10.1093/bioinformatics/btr355 · DOI · Paper page
- Altschul, 1990, Basic local alignment search tool, J. Mol. Biol, 215, 403, 10.1016/S0022-2836(05)80360-2 · doi:10.1016/s0022-2836(05)80360-2 · Paper page
- Grabherr, 2011, Full-length transcriptome assembly from RNA-Seq data without a reference genome, Nat. Biotechnol, 29, 644, 10.1038/nbt.1883 · DOI · Paper page
- Rosethorne, 2004, ATP priming of macrophage-derived chemokine responses in CHO cells expressing the CCR4 receptor, Naunyn Schmiedebergs Arch. Pharmacol, 370, 64, 10.1007/s00210-004-0932-7 · DOI
- Ames, 2001, Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models, J. Immunol, 166, 6341, 10.4049/jimmunol.166.10.6341 · DOI · Paper page
- Martin, 1997, The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes, J. Exp. Med, 186, 199, 10.1084/jem.186.2.199 · DOI · Paper page
- Aguilar, 2013, Characterization of the reproductive effects of the Vgf -derived peptide TLQP-21 in female rats: in vivo and in vitro studies, Neuroendocrinology, 98, 38, 10.1159/000350323 · DOI
- Settmacher, 2003, Structure-function studies of the C3a-receptor: C-terminal serine and threonine residues which influence receptor internalization and signaling, Eur. J. Immunol, 33, 920, 10.1002/eji.200323293 · DOI
- Lim, 2013, C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling, FASEB J, 27, 822, 10.1096/fj.12-220582 · DOI · Paper page
- Hahm, 2002, VGF is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide Y-containing arcuate neurons in response to fasting, J. Neurosci, 22, 6929, 10.1523/JNEUROSCI.22-16-06929.2002 · DOI · Paper page
- Levi, 1985, Molecular cloning of a gene sequence regulated by nerve growth factor, Science, 229, 393, 10.1126/science.3839317 · DOI · Paper page
- Rahpeymai, 2006, Complement: a novel factor in basal and ischemia-induced neurogenesis, EMBO J, 25, 1364, 10.1038/sj.emboj.7601004 · DOI · Paper page
- Bénard, 2008, Role of complement anaphylatoxin receptors (C3aR, C5aR) in the development of the rat cerebellum, Mol. Immunol, 45, 3767, 10.1016/j.molimm.2008.05.027 · DOI
- Gao, 2003, Sulfation of tyrosine 174 in the human C3a receptor is essential for binding of C3a anaphylatoxin, J. Biol. Chem, 278, 37902, 10.1074/jbc.M306061200 · DOI
Cited by
Coulthard, L. G., & Woodruff, T. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403068 · Cited by 285
El Gaamouch, F., Audrain, M., Lin, W.-J., Beckmann, N., Jiang, C., Hariharan, S., Heeger, P. S., Schadt, E. E., Gandy, S., Ehrlich, M. E., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-0357-x · Cited by 92
“C3aR1 is a receptor for TLQP-21 [5, 24, 25, 29] and is predominantly expressed by microglia in the brain [71].”
BackgroundCero, C., Vostrikov, V. V., Verardi, R., Severini, C., Gopinath, T., Braun, P. D., Sassano, M. F., Gurney, A., Roth, B. L., Vulchanova, L., et al. (2014) · Structure · doi:10.1016/j.str.2014.10.001 · Cited by 71
Clearance kinetics of the VGF-derived neuropeptide TLQP-21
Guo, Z., Sahu, B. S., He, R., Finan, B., Cero, C., Verardi, R., Razzoli, M., Veglia, G., Di Marchi, R. D., Miles, J. M., et al. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.06.003 · Cited by 21
Metadata
- Authors
- Hannedouche, S., Beck, V., Leighton-Davies, J., Beibel, M., Roma, G., Oakeley, E. J., Lannoy, V., Bernard, J., Hamon, J., Barbieri, S., Preuss, I., Lasbennes, M.-C., Sailer, A. W., Suply, T., Seuwen, K., Parker, C. N., & Bassilana, F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 288
- Issue
- 38
- Pages
- 27434-27443
- ISSN
- 0021-9258
- Cited by
- 91
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 2564 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.